Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects

Stem Cell Res. 2023 Sep:71:103156. doi: 10.1016/j.scr.2023.103156. Epub 2023 Jun 24.

Abstract

Down syndrome is a congenital disorder resulting from an extra full or partial chromosome 21, which is characterized by a spectrum of systemic developmental abnormalities, including those affecting the cardiovascular system. Here, we generated an iPSC line from peripheral blood mononuclear cells of a male adolescent with Down syndrome-associated congenital heart defects through Sendai virus-mediated transfection of 4 Yamanaka factors. This line exhibited normal morphology, expressed pluripotency markers, trisomy 21 karyotype, and could be differentiated into three germ layers. This iPSC line can be used for studying cellular and developmental etiologies of congenital heart defects induced by aneuploidy of chromosome 21.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Cell Differentiation
  • Cell Line
  • Cellular Reprogramming
  • Down Syndrome* / complications
  • Genetic Vectors
  • Heart Defects, Congenital* / genetics
  • Humans
  • Induced Pluripotent Stem Cells*
  • Leukocytes, Mononuclear
  • Male
  • Transcription Factors / genetics

Substances

  • Transcription Factors